MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Age-associated Changes in Microglial Morphology and its Role in Deciphering Susceptibility to Parkinson’s Disease

    S. Choudhury, P. Abhilash, P. Alladi (Bengaluru, India)

    Objective: To delineate the age-associated changes in microglial morphotypes in the substantia nigra pars compacta (SNpc) of C57BL/6J and CD-1 mice and alterations in response…
  • 2024 International Congress

    The role of pathology validation on the association between smoking and Parkinson’s Disease

    P. Pecoraro, S. Carbone, F. Alessi, V. Di Lazzaro, L. Di Biase (Rome, Italy)

    Objective: The aim of this study is to investigate the relationship between smoking and Parkinson’s disease in pathology validated Parkinson’s disease patients. Background: Literature has…
  • 2024 International Congress

    Levels of ferritinemia in Parkinson’s disease patients who underwent Covid-19

    B. Amonov, R. Matmurodov, B. Muminov (Tashkent, Uzbekistan)

    Objective: Comparison of serum IL-6 levels in Parkinson's disease (PD) patients with and without Сovid-19. Background: In the scientific literature, there is information about the…
  • 2024 International Congress

    Effects of Osteopathic Manipulative Treatment (OMT) on Lower Extremity Muscle Characteristics in Parkinson’s Disease (PD) Patients

    R. Radigan, A. Finkelstein, M. Mehra, P. Bhushan, T. Lombardo, S. Yao (Old Westbury, USA)

    Objective: To define the mechanism of Osteopathic Manipulative Treatment (OMT) in decreasing symptomology and improving gait in Parkinson’s Disease (PD) patients. Background: A key symptom…
  • 2024 International Congress

    Investigating Interrater Reliability of the Unified Huntington’s Disease Rating Scale Motor Component Between Learner and Experienced Rater

    M. Janz, W. Adams, A. Key, R. Zschiegner, D. Burks, K. Shannon, J. Paulsen (Madison, USA)

    Objective: The aim of this project is to explore the interrater reliability of the standardized motor exam of the Unified Huntington’s Disease Rating Scale (UHDRS)…
  • 2024 International Congress

    Botulinum Toxin A Usage in Movement Disorder Division: A Retrospective Chart Review

    S. Shaikh, R. Figari Jordan (Charlottesville, USA)

    Objective: To evaluate the cost-effectiveness of Botulinum Toxin A in our movement disorder division. Background: Botulinum Toxin A is an FDA-approved treatment for various medical…
  • 2024 International Congress

    Patient and Caregiver Experiences with Tardive Dyskinesia: Emotions, Challenges, and Unmet Needs in the Patient Journey

    A. Peyser Levin, E. Kinjo, R. Ribalov, N. Chaijale, A. Yaari (Tel Aviv, Israel)

    Objective: To describe the emotional journey from symptom onset to current state and identify challenges and unmet needs of participants living with tardive dyskinesia (TD)…
  • 2024 International Congress

    Triple threat: A rare case of a patient with 3 co-existent autoimmune antibodies causing autonomic and movement disorder

    YK. Kim, KC. Colletta (Maywood, USA)

    Objective: We describe a unique case of a patient with a constellation of movement and autonomic abnormalities. Serum paraneoplastic/autoimmune testing was positive for 3 separate…
  • 2024 International Congress

    Catalan MSA Registry (CMSAR): Applying new Clinical Criteria and Biomarkers for Increasing Diagnostic Accuracy, is New Better?

    A. Pérez-Soriano, C. Painous, J. Pérez, M. Fernandez, Y. Compta, Consortium, MJ. Martí (Barcelona, Spain)

    Objective: To reassess the CMSAR and determine if new criteria and new biomarkers can enhance diagnostic accuracy. Background: The CMSAR, conducted between 2015 and 2019,…
  • 2024 International Congress

    Prognostic role of postganglionic cardiovascular dysfunction in Multiple System Atrophy

    R. Telese, A. Elia, R. Cilia, F. Colucci, V. Leta, A. Braccia, L. Romito, R. Eleopra, G. Devigili (Milan, Italy)

    Objective: To evaluate the role of reduced cardiac postganglionic sympathetic innervation as a prognostic factor in Multiple System Atrophy(MSA) Background: Cardiovascular autonomic dysfunction in MSA…
  • « Previous Page
  • 1
  • …
  • 145
  • 146
  • 147
  • 148
  • 149
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley